Trade Summary

2 months ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Spyglass Pharma, Inc. (SGP), purchased 3,690,000 shares at $16.00 per share, for a total transaction value of $59,040,000.00. Following this transaction, Ra Capital Management, L.P. now holds 2,054,678 shares of SGP.

This purchase represents a 226.00% decrease in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Spyglass Pharma, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.